These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 14766884)

  • 81. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
    Mokaddas EM; Al-Sweih NA; Khan ZU
    J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Study on in vitro susceptibility of Candida spp. isolated from blood culture].
    Grandesso S; Sapino B; Mazzuccato S; Solinas M; Bedin M; D'Angelo M; Gion M
    Infez Med; 2012 Mar; 20(1):25-30. PubMed ID: 22475657
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility.
    Lozano-Chiu M; Arikan S; Paetznick VL; Anaissie EJ; Rex JH
    J Clin Microbiol; 1999 Sep; 37(9):2755-9. PubMed ID: 10449447
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
    Astvad KMT; Hare RK; Arendrup MC
    Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates.
    Koehling HL; Willinger B; Buer J; Rath PM; Steinmann J
    J Clin Microbiol; 2015 Jan; 53(1):255-61. PubMed ID: 25392352
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
    Pfaller MA; Arikan S; Lozano-Chiu M; Chen Y; Coffman S; Messer SA; Rennie R; Sand C; Heffner T; Rex JH; Wang J; Yamane N
    J Clin Microbiol; 1998 Sep; 36(9):2609-12. PubMed ID: 9705401
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [TBL] [Abstract][Full Text] [Related]  

  • 91. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study.
    Lei J; Xu J; Wang T
    J Mycol Med; 2018 Jun; 28(2):310-313. PubMed ID: 29685520
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vitro activities of fluconazole and voriconazole against clinical isolates of Candida spp. determined by disk diffusion testing in Turin, Italy.
    Mandras N; Tullio V; Allizond V; Scalas D; Banche G; Roana J; Robbiano F; Fucale G; Malabaila A; Cuffini AM; Carlone N
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1657-9. PubMed ID: 19188375
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
    Pfaller MA; Boyken L; Messer SA; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2005 Oct; 43(10):5208-13. PubMed ID: 16207985
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole.
    Pfaller MA; Boyken L; Messer SA; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2004 Mar; 42(3):1288-9. PubMed ID: 15004097
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparison of the Sensititre YeastOne antifungal method with the CLSI M27-A3 reference method to determine the activity of antifungal agents against clinical isolates of Candidaspp.
    Altinbaş R; Barış A; Şen S; Öztürk R; Kiraz N
    Turk J Med Sci; 2020 Dec; 50(8):2024-2031. PubMed ID: 32659879
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In vitro susceptibility testing of Geotrichum capitatum: comparison of the E-test, disk diffusion, and Sensititre colorimetric methods with the NCCLS M27-A2 broth microdilution reference method.
    Girmenia C; Pizzarelli G; D'Antonio D; Cristini F; Martino P
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3985-8. PubMed ID: 14638517
    [TBL] [Abstract][Full Text] [Related]  

  • 97. In vitro synergy of eugenol on the antifungal effects of voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares.
    Sharifzadeh A; Shokri H
    Equine Vet J; 2021 Jan; 53(1):94-101. PubMed ID: 32298479
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evaluation of voriconazole pharmacodynamics using time-kill methodology.
    Klepser ME; Malone D; Lewis RE; Ernst EJ; Pfaller MA
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1917-20. PubMed ID: 10858354
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpoints.
    Santos ER; Dal Forno CF; Hernandez MG; Kubiça TF; Venturini TP; Chassot F; Santurio JM; Alves SH
    Rev Inst Med Trop Sao Paulo; 2014; 56(6):477-82. PubMed ID: 25351540
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Usefulness of the Sensititre YeastOne® panel to detect Candida species resistant to antifungal drugs].
    Córdoba S; Abiega C; Agorio I; Amigot S; Ardizzoli K; Giusiano G; Guelfand L; López Moral L; Maldonado I; Pineda G; Garcia-Effron G;
    Rev Argent Microbiol; 2022; 54(1):9-14. PubMed ID: 33875292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.